In the present study we proved for the first time that preventive treatment with U50,488H showed a significant effect to ameliorate endothelial dysfunction in hyperlipidemia through activation of κ-OR and the PI3K/Akt/eNOS pathway. This evidence concerns the gene OPRK1 and hyperlipidemia.